PTAB Must Redo Suboxone Patent Reviews Post-SAS
The Federal Circuit on Tuesday threw out decisions from the U.S. Patent Trial and Appeal Board that upheld parts of an Aquestive Therapeutics Inc. patent related to opioid addiction treatment Suboxone,...To view the full article, register now.
Already a subscriber? Click here to view full article